Aeterna Zentaris Inc AEZS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
7.84quote price arrow down-0.20 (-2.49%)
Volume
19,867
52 week range
5.44 - 13.20
Loading...
  • Open7.80
  • Day High8.35
  • Day Low7.74
  • Prev Close8.04
  • 52 Week High13.20
  • 52 Week High Date05/08/23
  • 52 Week Low5.44
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap38.07M
  • Shares Out4.86M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change4.84

KEY STATS

  • Open7.80
  • Day High8.35
  • Day Low7.74
  • Prev Close8.04
  • 52 Week High13.20
  • 52 Week High Date05/08/23
  • 52 Week Low5.44
  • 52 Week Low Date11/01/23
  • Market Cap38.07M
  • Shares Out4.86M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change4.84

RATIOS/PROFITABILITY

  • EPS (TTM)-13.64
  • P/E (TTM)-0.57
  • Fwd P/E (NTM)-1.23
  • EBITDA (TTM)-17.839M
  • ROE (TTM)-61.34%
  • Revenue (TTM)4.498M
  • Gross Margin (TTM)95.06%
  • Net Margin (TTM)-368.01%
  • Debt To Equity (MRQ)1.53%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aeterna Zentaris Inc

 

Profile

MORE
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin...
Carolyn Egbert J.D., Ph.D.
Non-Executive Independent Chairman of the Board
Klaus Paulini Ph.D.
President, Chief Executive Officer, Director and Managing Director - AEZS Germany
Giuliano La Fratta
Chief Financial Officer, Senior Vice President
Address
315 Sigma Drive
Summerville, NB
29486
Canada

Top Peers

SYMBOLLASTCHG%CHG
AEZS
Aeterna Zentaris Inc
7.84-0.20-2.49%
ATE
KTRA
Kintara Therapeutics Inc
0.1513-0.0059-3.7532%
PRTG
Portage Biotech Inc
0.271+0.0111+4.2709%
EDSA
Edesa Biotech Inc
4.54-0.01-0.33%